The potential of this technique was first shown in the non-invasive detection of Kras mutations in stool samples of colorectal cancer patients [38] and more recently for the detection of T790M mutations in the circulating tumour DNA of NSCLC patients [39]. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.